Furthermore, the interferon response can increase the expression of immune checkpoint molecules on tumor cells, such as programmed cell death ligand 1 (PD-L1) and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). The gene discussed is CTLA4; the disease is neoplasm.